News About: Pharm. Industry
KORUS FTA takes effect from today
From today, the free trade agreement between Korea and the United States (KORUS FTA) goes into effect on March 15, six years after the two countries kicked off talks on the trade pact in June 2006.
Trade Minister ...
Smaller pharmaceutical firms’ sales up, profitability down
A total of 17 pharmaceutical firms listed on KOSDAQ market saw their revenues and operating incomes increase on-year 2011. But their ability to generate cash from a variety of operating activities fell 16 percent on w...
Korean Drugmakers at a Crossroads
Many experts say that coupled with the government’s plan to slash insurance drug prices, the country's medicine business is standing at a crossroads as the free trade pact between Korea and the United States takes eff...
KPMA unable to agree on joint legal action against government drug pricing reform
The Korea Pharmaceutical Manufacturers Association Wednesday adjourned with no agreement on how to respond to the government’s plan to slash drug prices next month.
The association called in its 70 member companies...
Yuyu to supply osteoporosis combination drug to Thailand
Yuyu Pharmaceutical Co. Ltd. said Wednesday that it will make the first shipment of Maxmarvil tablets, the world’s first new combination drug containing alendronate, to Thailand following execution of the distribution...
70% of pharmaceutical firms fared worse in 2011: Data
Twenty five of the nation's leading 35 drug firms performed worse last year than in 2010, as the government punished both distributors and medical personnel if the latter is found to have received a “rebate” or kickba...
Labor dispute looms large at Abbott Korea
Abbott Korea and unionists are on a collision course over collective negotiation rights.
On March 13, the Abbott union held a rally in front of Abbott headquarters to protest the company’s rejection over the labor’...
KPA seeking to settle pricing difference issue
The Korean Pharmaceutical Association plans to deal with the price differences of pharmaceuticals within April as the prices of 6,506 drugs given on the National Health Insurance scheme will fall by 14 percent on aver...
Drug makers keen on selection of innovative pharmaceutical firms
Aside from their legal action against the government’s plan to slash drug prices in April, all eyes in the domestic pharmaceutical industry are on the Ministry for Health, Welfare and Family Affair's decision on the d...
Korea’s pharmaceutical advertising market likely to expand this year
The domestic pharmaceutical and medical advertising market is expected to grow this year as drug firms are willing to make up for the significant losses to be affected by the government’s imminent plan to slash insura...
